CRISPRの世界市場:インサイト、機会分析、市場シェア、予測

◆英語タイトル:Global CRISPR Market Insights, Opportunity Analysis, Market Shares and Forecast 2016 – 2022
◆商品コード:OCCAM60512
◆発行会社(調査会社):Occams Research
◆発行日:2016年4月29日
◆ページ数:140
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:バイオ技術
◆販売価格オプション(消費税別)
Single UserUSD3,900 ⇒換算¥444,600見積依頼/購入/質問フォーム
Enterprisewide Price (Global Site License)USD6,900 ⇒換算¥786,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はOccams Research社の日本における正規販売代理店です。Occams Research社の概要及び新刊レポートはこちらでご確認いただけます。
【レポートの概要】

Clustered regularly-interspaced short palindromic repeats also known as CRISPR is a gene editing tool. CRIPSR commercialization began in 2012 with emergence of number of startups and venture capitalists and showing their interest in infusing money into this technology. Academic and research firms are the main consumers of CRISPR gene editing tool followed by biotechnology companies. The number of patents for CRISPR is outclassing the patents of other gene editing tools such as ZFN and TALEN. The market is driven by high demand for plasmids, synthetic genes and high quality gene slicing techniques. Growing drug discovery, biotechnology and proteomics markets are also driving the market growth.
The market is This is driven by the fact that CRISPR is a new technology which is simple, more efficient and cost effective as compared to its peers. High adoption both in biotech and pharma industry along with high level of research is also responsible for high growth rate.

The market for CRISPR technology is niche. The number of companies are still very less and most of the companies are start-ups which are going through rounds of funding. Some of the major companies include Editas, Intellia, Sigma Eldrich, Oregene, Gene Script, Thermo Fisher Scientific and others. Most of the companies are working on developing CRISPR products along with the approval and commercialization of such products. These companies have successfully attracted major investments from big VC firms and companies such as Google and DuPont. These companies are relying on the disruptive nature of the technology. CRISPR has the capability to open new markets for gene surgery and genetically modified organisms. However, there are major concerns from the scientific community regarding the misuse of such technology in human cloning. Geographically North America leads the market race followed by Europe and Asia Pacific.

Companies profiled include
1. Thermo Fisher Scientific
2. Editas Medicine
3. Caribou Biosciences
4. CRISPR therapeutics
5. Intellia
6. Cellectis
7. Horizon discovery PLC
8. Sigma Aldrich
9. Precision biosciences
10. GenScript
11. Sangamo Biosciences Inc.
12. Lonza group limited
13. Integrated DNA technologies
14. New England Biolabs
15. Oregene Technologies
16. Transposgen Biopharmaceuticals

This Occams Research report covers
1. Historical data
2. Revenue forecasts, growth rates and CAGR up to 2021
3. Industry Analysis
4. Competitive Analysis
5. Key geographic growth data

【レポートの目次】

1. Executive Summary
1.1. Estimation Methodology

2. Market Overview
2.1. CRISPR- Introduction
2.2. Value chain analysis
2.3. Key buying criteria
2.4. Research and development
2.4.1. Patent analysis
2.5. CRISPR vs. Conventional gene editing tools
2.5.1. TALEN
2.5.2. ZFN
2.6. CRISPR: Novel initiatives
2.6.1. CRISPR/Cas9 technology
2.6.2. CRISPR as a gene editing tool to treat genetic disorders.
2.6.3. CRISP as a gene editing tool in drug development.
2.7. Strategic Recommendation and conclusion

3. Sector Analysis
3.1. Gene Editing Market

4. Market Determinants
4.1. Drivers
4.1.1. Rise in drug discovery market
4.1.2. Demand for synthetic genes
4.1.3. High prevalence of genetic birth disorders
4.1.4. Age related genetic disorders
4.1.5. Rise in the healthcare research and development budgets
4.1.6. Venture capital
4.2. Restraints
4.2.1. Ethical issues related to misuse of CRISPR gene editing tool
4.2.2 Limited awareness
4.2.3. Limited presence in Emerging markets
4.3. Opportunities
4.3.1 CRISPR gene editing can open the market for gene surgery.
4.3.2. Emerging contract research market in Asia
4.4. Challenges
4.4.1. Patent infringement
4.4.2. Presence of alternative gene editing tools

5. Market Segmentation
5.1. By Application
5.1.1. Genome Editing
5.1.2. Genetic engineering
5.1.3. gRNA Database/Gene Library
5.1.4. CRISPR Plasmid
5.1.5. Human Stem Cells
5.1.6. Genetically modified organisms/crops
5.1.7. Cell line engineering
5.2. By End user
5.2.1. Biotechnology companies
5.2.2. Pharmaceutical companies
5.2.3. Academic Institutes
5.2.4. Research and development institutes
5.3. Competitive Intelligence
5.3.1. Merger and Acquisitions
5.3.2. Innovation
5.3.3. Venture capital funding

6. Geographical Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. United Kingdom
6.2.2. France
6.2.3. Germany
6.2.4. Spain
6.2.5. Italy
6.3. Asia Pacific
6.3.1. China
6.3.2. Japan
6.3.3. India
6.4. Rest of the world

7. Company Profiling
1. Thermo Fisher Scientific
2. Editas Medicine
3. Caribou Biosciences
4. CRISPR therapeutics
5. Intellia
6. Cellectis
7. Horizon discovery PLC
8. Sigma Aldrich
9. Precision biosciences
10. GenScript
11. Sangamo Biosciences Inc.
12. Lonza group limited
13. Integrated DNA technologies
14. New England Biolabs
15. Oregene Technologies
16. Transposgen Biopharmaceuticals

1. GLOBAL CRISPR MARKET BY APPLICATION 2014-2022 ($ MILLION)

2. GLOBAL GENOME EDITING MARKET BY REGION 2014-2022 ($ MILLION)
3. GLOBAL GENE LIBRARY MARKET BY REGION 2014-2022 ($ MILLION)
4. GLOBAL CRISPR PLASMIDS MARKET BY REGION 2014-2022 ($ MILLION)
5. GLOBAL CRISPR MARKET BY END USER 2014-2022 ($ MILLION)
6. GLOBAL CRISPR MARKET BY BIOTECHNOLOGY COMPANIES 2014-2022 ($ MILLION)
7. GLOBAL CRISPR MARKET BY PHARMACEUTICAL COMPANIES 2014-2022 ($ MILLION)
8. GLOBAL CRISPR MARKET BY ACADEMIC INSTITUTES 2014-2022 ($ MILLION)
9. GLOBAL CRISPR MARKET BY R&D INSTITUTES 2014-2022 ($ MILLION)
10. GLOBAL CRISPR MARKET BY REGION 2014-2022 ($ MILLION)
11. NORTH AMERICAN CRISPR MARKET 2014-2022 ($ MILLION)
12. EUROPEAN CRISPR MARKET 2014-2022 ($ MILLION)
13. ASIA PACIFIC CRISPR MARKET 2014-2022 ($ MILLION)



1. UNITED STATES CRISPR MARKET 2014-2022 ($ MILLION)
2. CANADA CRISPR MARKET 2014-2022 ($ MILLION)

3. UNITED KINGDOM CRISPR MARKET 2014-2022 ($ MILLION)
4. FRANCE CRISPR MARKET 2014-2022 ($ MILLION)
5. GERMANY CRISPR MARKET 2014-2022 ($ MILLION)
6. SPAIN CRISPR MARKET 2014-2022 ($ MILLION)
7. ITALY CRISPR MARKET 2014-2022 ($ MILLION)

8. CHINA CRISPR MARKET 2014-2022 ($ MILLION)
9. JAPAN CRISPR MARKET 2014-2022 ($ MILLION)
10. INDIA CRISPR MARKET 2014-2022 ($ MILLION)
11. REST OF THE WORLD CRISPR MARKET 2014-2022 ($ MILLION)



★調査レポート[CRISPRの世界市場:インサイト、機会分析、市場シェア、予測]販売に関する免責事項
★調査レポート[CRISPRの世界市場:インサイト、機会分析、市場シェア、予測]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆